259 related articles for article (PubMed ID: 12438445)
1. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
[TBL] [Abstract][Full Text] [Related]
2. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease.
Palmer BE; Mack DG; Martin AK; Maier LA; Fontenot AP
J Allergy Clin Immunol; 2007 Jul; 120(1):184-91. PubMed ID: 17416406
[TBL] [Abstract][Full Text] [Related]
3. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
Fontenot AP; Palmer BE; Sullivan AK; Joslin FG; Wilson CC; Maier LA; Newman LS; Kotzin BL
J Clin Invest; 2005 Oct; 115(10):2886-93. PubMed ID: 16151531
[TBL] [Abstract][Full Text] [Related]
4. Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation.
Chain JL; Martin AK; Mack DG; Maier LA; Palmer BE; Fontenot AP
J Immunol; 2013 Aug; 191(4):1648-56. PubMed ID: 23851684
[TBL] [Abstract][Full Text] [Related]
5. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
Fontenot AP; Kotzin BL; Comment CE; Newman LS
Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
[TBL] [Abstract][Full Text] [Related]
6. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.
Palmer BE; Mack DG; Martin AK; Gillespie M; Mroz MM; Maier LA; Fontenot AP
J Immunol; 2008 Feb; 180(4):2704-12. PubMed ID: 18250483
[TBL] [Abstract][Full Text] [Related]
8. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
[TBL] [Abstract][Full Text] [Related]
9. 4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease.
Mack DG; Lanham AK; Palmer BE; Maier LA; Watts TH; Fontenot AP
J Immunol; 2008 Sep; 181(6):4381-8. PubMed ID: 18768897
[TBL] [Abstract][Full Text] [Related]
10. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
[TBL] [Abstract][Full Text] [Related]
11. Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease.
Pott GB; Palmer BE; Sullivan AK; Silviera L; Maier LA; Newman LS; Kotzin BL; Fontenot AP
J Allergy Clin Immunol; 2005 May; 115(5):1036-42. PubMed ID: 15867863
[TBL] [Abstract][Full Text] [Related]
12. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
[TBL] [Abstract][Full Text] [Related]
14. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
Tinkle SS; Kittle LA; Newman LS
J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
[TBL] [Abstract][Full Text] [Related]
15. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.
Dobis DR; Sawyer RT; Gillespie MM; Newman LS; Maier LA; Day BJ
Am J Respir Cell Mol Biol; 2010 Oct; 43(4):458-64. PubMed ID: 19901345
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease.
Tinkle SS; Schwitters PW; Newman LS
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043
[TBL] [Abstract][Full Text] [Related]
17. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.
Greaves SA; Atif SM; Fontenot AP
Front Immunol; 2020; 11():474. PubMed ID: 32256501
[TBL] [Abstract][Full Text] [Related]
18. Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation.
Falta MT; Crawford JC; Tinega AN; Landry LG; Crawford F; Mack DG; Martin AK; Atif SM; Li L; Santos RG; Nakayama M; Kappler JW; Maier LA; Thomas PG; Pinilla C; Fontenot AP
J Clin Invest; 2021 May; 131(9):. PubMed ID: 33630763
[TBL] [Abstract][Full Text] [Related]
19. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity.
Fontenot AP; Kotzin BL
Tissue Antigens; 2003 Dec; 62(6):449-58. PubMed ID: 14617028
[TBL] [Abstract][Full Text] [Related]
20. Chronic granulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice.
Nikula KJ; Swafford DS; Hoover MD; Tohulka MD; Finch GL
Toxicol Pathol; 1997; 25(1):2-12. PubMed ID: 9061844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
